Apple Halts US Sales of New Watches Due to Patent Dispute
By Rediff Money Desk, CUPERTINO Dec 19, 2023 19:06
Apple suspends US sales of Series 9 and Ultra 2 Apple Watches with Blood Oxygen feature due to an ITC order stemming from a patent dispute with Masimo. The White House is reviewing the order.
Cupertino (US), Dec 19 (AP) If two of the latest Apple Watches are on your holiday shopping list, don't dawdle for much longer because the devices won't be available to buy in the US later this week if the White House doesn't intervene in an international patent dispute.
Apple plans to suspend sales of the Series 9 and Ultra 2 versions of its popular watch for online US customers beginning Thursday afternoon and in its stores on Sunday. The move stems from an October decision by the International Trade Commission restricting Apple's watches with the Blood Oxygen measurement feature as part of an intellectual property dispute with medical technology company Masimo.
The White House had 60 days to review the ITC order issued on Oct 26, meaning Apple could have kept selling the two affected models in the US through Christmas. But the Cupertino, California, company said in a Monday statement that it is pausing sales early to ensure it complies with the ITC order.
If the ITC's sales ban isn't overturned, Apple pledged to take all measures to resume sales of the Series 9 and Ultra 2 models in the US as soon as possible.
The Apple Watch SE, which lacks the Blood Oxygen feature, will remain on sale in the US after Christmas Eve. Previously purchased Apple Watches equipped with the Blood Oxygen aren't affected by the ITC order.
Apple plans to suspend sales of the Series 9 and Ultra 2 versions of its popular watch for online US customers beginning Thursday afternoon and in its stores on Sunday. The move stems from an October decision by the International Trade Commission restricting Apple's watches with the Blood Oxygen measurement feature as part of an intellectual property dispute with medical technology company Masimo.
The White House had 60 days to review the ITC order issued on Oct 26, meaning Apple could have kept selling the two affected models in the US through Christmas. But the Cupertino, California, company said in a Monday statement that it is pausing sales early to ensure it complies with the ITC order.
If the ITC's sales ban isn't overturned, Apple pledged to take all measures to resume sales of the Series 9 and Ultra 2 models in the US as soon as possible.
The Apple Watch SE, which lacks the Blood Oxygen feature, will remain on sale in the US after Christmas Eve. Previously purchased Apple Watches equipped with the Blood Oxygen aren't affected by the ITC order.
Read More On:
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Srestha Finvest
- 0.69 (+ 1.47)
- 126417084
- Vodafone Idea L
- 7.83 ( -0.63)
- 31781037
- AvanceTechnologies
- 0.98 (+ 4.26)
- 25713039
- ARC Finance
- 2.86 (+ 2.88)
- 21781320
- Suzlon Energy Ltd.
- 62.15 ( -0.56)
- 18524212
MORE NEWS
Ramco Cements Q2 Profit Falls 64.2% to Rs 25.8...
Ramco Cements reports a 64.2% decline in Q2 net profit to Rs 25.8 crore due to lower...
India Semiconductor Jobs: 1 Million by 2026
India's semiconductor sector is set to create 1 million jobs by 2026, driven by...
Hindalco Q2 Profit Surges 78% to Rs 3,909 cr -...
Hindalco Industries reports a significant 78% jump in Q2 net profit to Rs 3,909 crore...